{
    "clinical_study": {
        "@rank": "73845", 
        "arm_group": {
            "arm_group_label": "CVInsight (TM)", 
            "arm_group_type": "Experimental", 
            "description": "Patient will be placed on a tilt table and pulse oximetry (Nonin Medical)and blood pressure will be measured at different table positions (different angles). A hemodynamic monitor called CVInsight(TM) will be used to monitor the pulse oximeter readings."
        }, 
        "brief_summary": {
            "textblock": "This is a single-center, non-randomized study.Enrolled patients  will be placed on a tilt\n      table and a stress test will be performed in a total of 4 different positions. Their blood\n      pressure will be measured at each position. Also, a pulse oximeter will be placed on the\n      forehead to measure pulse rate and strength. These results will be compared to cardiac\n      functional classifications defined by New York Heart Association (NYHA) criteria for adults\n      and New York Pediatric Heart Failure (NYPHF) index for our pediatric age patients. The\n      primary aim of this initiative is to assess the discriminatory value of a cardiac functional\n      health classification based upon the degree of dependency of cardiac function on changes in\n      cardiac preload and afterload circulatory volume."
        }, 
        "brief_title": "Developing a Non-invasive Cardiac Functional Health Status Measurement Device", 
        "completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "condition": "Heart Failure", 
        "condition_browse": {
            "mesh_term": "Heart Failure"
        }, 
        "detailed_description": {
            "textblock": "Participants will be asked to review the informed consent and consent to the study prior to\n      any study procedures. The study will consist of a single visit to the Medical Plaza at the\n      University of Florida. During this visit, Enrolled patients will be placed on a tilt table\n      and their position changed to a total of 4 different positions. Their blood pressure will be\n      measured at each position. Also, a pulse oximeter will be placed on the forehead to measure\n      pulse rate and strength. The study will take approximately 25 minutes. Data collected shall\n      include a questionnaire for the patient, a list of the patient's co-morbidities, an\n      echocardiogram or catheter lab data if available, and a list of the patient's current\n      medications."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Heart failure patient eligibility shall consist of the following:\n\n        Group 1a: 5 adult heart transplant patients\n\n          -  Age \u2265 21 years old and <74 years old\n\n          -  Speaks and understands English\n\n          -  Provides Informed Consent\n\n        Group 1b: 5 adult heart transplant patients\n\n          -  Age \u2265 7 years old and < 21 years old\n\n          -  Speaks and understands English\n\n          -  Provides Informed Consent\n\n        Group 2: 5 adult heart failure patients\n\n          -  Age \u2265 201 years old and <74 years old\n\n          -  Speaks and understands English\n\n          -  Provides Informed Consent\n\n        Group 3: 5 adult aged Fontan patients\n\n          -  Age \u2265 21 years old and <74 years old\n\n          -  Speaks and understands English\n\n          -  Provides Informed Consent\n\n        Group 4: 5 pediatric Fontan patients\n\n          -  Age \u2265 7 years old and < 21 years old\n\n          -  Speaks and understands English\n\n          -  Provides Informed Consent\n\n        Group 5: 5 pediatric patients limited to heart murmurs\n\n          -  Age \u2265 7 years old and < 21 years old\n\n          -  Speaks and understands English\n\n          -  Provides Informed Consent\n\n        Group 6: 5 normal adult patients\n\n          -  Age \u2265 21 years old and <74 years old\n\n          -  Speaks and understands English\n\n          -  Provides Informed Consent\n\n        Exclusion Criteria:\n\n          -  \u2022 Unstable  patients per judgment of the clinician prior to the start of the\n             treatment\n\n               -  Patients unable to have blood pressure cuff measured on the upper arm\n\n               -  Inability to wear monitor on forehead\n\n               -  Patients will be excluded from the study if they have eaten, consume caffeinated\n                  beverages, or taken hypertensive medications within 2 hours of testing"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "74 Years", 
            "minimum_age": "7 Years"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "April 15, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01877343", 
            "org_study_id": "IRB201300055"
        }, 
        "intervention": {
            "arm_group_label": "CVInsight (TM)", 
            "description": "Patient will be placed on a tilt table and pulse oximetry (Nonin Medical) and blood pressure will be measured at different table positions (different angles). Four positions will be explored.  A hemodynamic monitor called CVInsight(TM) will be used to monitor the pulse oximeter readings.", 
            "intervention_name": "CVInsight(TM)", 
            "intervention_type": "Device", 
            "other_name": "CVInsight(TM)"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "cardiac functional health classification", 
            "Congenital heart failure", 
            "chronic heart failure"
        ], 
        "lastchanged_date": "April 10, 2014", 
        "location": {
            "contact": {
                "email": "degroffc@ulf.edu", 
                "last_name": "Curt DeGroff, MD", 
                "phone": "352-273-7770"
            }, 
            "facility": {
                "address": {
                    "city": "Gainesville", 
                    "country": "United States", 
                    "state": "Florida", 
                    "zip": "32610"
                }, 
                "name": "University of Florida"
            }, 
            "investigator": {
                "last_name": "Curt DeGroff, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "1", 
        "official_title": "Developing a Non-invasive Cardiac Functional Health Status Measurement Device to be Used in a Critical Population of Adults and Children With Heart Failure.", 
        "overall_contact": {
            "email": "degroffc@ufl.edu", 
            "last_name": "Curt DeGroff, MD", 
            "phone": "352-273-7770"
        }, 
        "overall_official": {
            "affiliation": "University of Florida", 
            "last_name": "Curt DeGroff, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "description": "Continuous change of pulse rate from baseline through the end of the study will be followed.Changes in pulse rate will be plotted against the four tilt table positions. Four positions will be explored, Mounting position, baseline, passive leg raise (cardiac preload dependent) and orthostasis head raise (cardiac afterload dependent). Patients go from mounting position, to baseline, to the corresponding position (passive leg raise or orthostasis head raise) and back to baseline. The assessment will take 30 minutes. From the graph, discrete slopes will be calculated and used to discriminate heart failure functional classes.", 
                "measure": "Pulse rate", 
                "safety_issue": "No", 
                "time_frame": "Continuous change from baseline to 30 minutes"
            }, 
            {
                "description": "Continuous change of pulse strength from baseline through the end of the study.Changes in pulse strength will be plotted against the four tilt table positions. Four positions will be explored, Mounting position, baseline, passive leg raise (cardiac preload dependent) and orthostasis head raise (cardiac afterload dependent). Patients go from mounting position, to baseline, to the corresponding position (passive leg raise or orthostasis head raise) and back to baseline. The assessment will take 30 minutes. Cardiac function curves will be constructed with the data collected.", 
                "measure": "Pulse strength", 
                "safety_issue": "No", 
                "time_frame": "Continuous change from baseline to 30 minutes"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01877343"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "University of Florida", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Florida", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "June 2013", 
        "study_design": "Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic", 
        "study_type": "Interventional", 
        "verification_date": "April 2014"
    }
}